Loading data for PLUR — first visit, this takes a few seconds.

アラート

Pluri Inc. (PLUR)

NasdaqCM: PLUR · リアルタイム株価 · USD

1.77

+0.01 (0.57%)

終値時点： Aug 21, 2026, 8:00 PM

1.71

-7.07%

時間外: 4:10 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

0.57% (1D)

データがありません

買気配	1.57
時価総額	18.45M
売上高（TTM）	1.08M
純利益（TTM）	-25.54M
	0.68
	-2.9
	n/a
	-0.9
PBR（TTM）	-0.96
PSR（TTM）	17.10
決算発表日	n/a

売気配	1.61
出来高	14,771
平均出来高（20日）	26,070
始値	1.75
前日終値	1.76
当日レンジ	1.73 - 1.77
52週レンジ	1.45 - 5.68
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

PLURについて

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal ce...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Jun 30, 2003

従業員数 127

上場取引所 NasdaqCM

ティッカー PLUR

ウェブサイト https://www.pluri-biotech.com

企業情報の全文

業績

2025年のPluriの売上高は1.34Mで、前年の326Kから309.82%の増加でした。利益は-22.58Mで、8.11%の増加でした。

財務諸表

決算サプライズ

PluriはNov 12, 2025に四半期決算を発表しました：

売上高は $167K で、予想を下回りました $0, うち -60.89% の前年比減少.
EPSは -0.65 で、予想を上回りました 0.09, うち 70.98% の前年比増加にあたります.

ニュース

2か月前 · Insider Monkey

Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In

We just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list. Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foo...

2か月前 · Simply Wall St.

Pluri Insider Ups Holding During Year

Insiders were net buyers of Pluri Inc.'s ( NASDAQ:PLUR ) stock during the past year. That is, insiders bought more...

3か月前 · Benzinga

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

NewcelX Ltd. reported its 2025 financial results, with leadership emphasizing a "transformative year" marked by merger completion, balance sheet improvements, and progress in its lead Type 1 diabetes ...

6か月前 · Associated Press Finance

Pluri: Fiscal Q2 Earnings Snapshot

HAIFA, Israel (AP) — Pluri Inc. PLUR) on Thursday reported a loss of $6.5 million in its fiscal second quarter. The Haifa, Israel-based company said it had a loss of 71 cents per share.

6か月前 · Proactive

Pluri showcases cell expansion platform as Resbiomed program advances

Pluri Inc CEO Yaky Yanay joined Steve Darling from Proactive to provide deeper insight into the company’s proprietary cell expansion technology and its strategic growth across both therapeutics and fo...

2ページ中1ページ